Evidence map›Paper›PMID 30103811›Full record

ReviewDiagnostic pathology2018

Melanotic Xp11 translocation renal cancer: a report of a distinctive case and a review of the literature.

Hongbiao Jing, Hong Wei, Hongtu Yuan, Yahong Li, Ning Li, Dianbin Mu

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Diagnostic pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Hongbiao JingDepartment of Pathology, Shandong Cancer Hospital Affiliated to Shandong University, No. 440 Jiyan Road, Jinan, 250117, China.
Hong WeiThe Sixth People Hospital of Jinan City, No. 308 Huiquan Road, Zhangqiu, 250200, China.
Hongtu YuanDepartment of Pathology, Shandong Cancer Hospital Affiliated to Shandong University, No. 440 Jiyan Road, Jinan, 250117, China.
Yahong LiGuangzhou LBP Medical Technology Co., Ltd, No. 11 Nanxiang Third Road, Guangzhou, 510663, China.
Ning LiThe Sixth People Hospital of Jinan City, No. 308 Huiquan Road, Zhangqiu, 250200, China.
Dianbin MuDepartment of Pathology, Shandong Cancer Hospital Affiliated to Shandong University, No. 440 Jiyan Road, Jinan, 250117, China. mudianbin@163.com.
Shandong Tumor Hospital · CNZhangqiu City People's Hospital · CNGuangzhou Electronic Technology (China) · CNShandong First Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelanotic Xp11 translocation renal cancer (TRC) is a newly described exceedingly rare tumor, and its characterization remains controversial. This study aimed to describe a case of distinctive melanotic Xp11 TRC and to elucidate its clinicopathological and molecular genetic features. CASE PRESENTATION: A 44-year-old Chinese female presented with a left renal mass. Abdominal ultrasonography and computed tomography (CT) scans revealed a 4.5 cm × 4.0 cm mass in the left kidney. Grossly, the well-demarcated mass was black with moderately firm consistency. Microscopic examination indicated that the tumor was characterized by the presence of nests and cords of polygonal cells with clear and granular eosinophilic cytoplasm, central round to oval nuclei and occasional nucleoli. Intracytoplasmic melanin was observed in approximately 45% of tumor cells. Uniquely, the tumor presented with intranuclear eosinophilic pseudoinclusions and thick-walled stromal blood vessels. IHC showed that tumor cells were diffusely positive for TFE3 and exhibited patchy and weak HMB45 staining. FISH confirmed the presence of TFE3 rearrangement.

conclusionThis case is the twentieth published case of melanotic Xp11 TRC. Moreover, the present patient had a favorable prognosis given that she was disease free at her 113-month postoperative follow-up. Our case adds to the small body of literature on these exceptionally rare tumors and widens their clinicopathological spectrum.

Indexed as

Chromosomes, Human, XTranslocation, GeneticAdultBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiopsyDiagnosis, DifferentialFemaleGene RearrangementGenetic Predisposition to Diseasegp100 Melanoma AntigenHumansImmunohistochemistryIn Situ Hybridization, FluorescenceKidney NeoplasmsMelaninsMelanoma-Specific AntigensBasic Helix-Loop-Helix Leucine Zipper Transcription Factorsgp100 Melanoma AntigenMelaninsMelanoma-Specific AntigensPMEL protein, humanTFE3 protein, humanKidneyMelaninNeoplasmTFE3TranslocationXp11

Identifiers

PMID30103811
PMCPMC6090727
OpenAlexW2886426738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.